IVBIX Fees and Costs — Delaware Ivy Core Bond Fund, Class I
Data updated: 2024-08-27
The net expense ratio is 0.44%: a 0.52% management fee plus 0.12% other expenses, less a 0.20% fee waiver. There are no sales loads or redemption fees. In fiscal 2024 the fund paid $21K in broker commissions, 0.0053% of average net assets, and portfolio turnover was 128%.
IVBIX Fees and Expenses
Annual operating expenses and sales charges of IVBIX. Prospectus, as of March 31, 2023.
| Annual operating expenses | |
|---|---|
| Management fee | 0.52% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.12% |
| Gross expense ratio | 0.64% |
| Fee waiver | −0.20% |
| Net expense ratio | 0.44% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
IVBIX Costs Over Time
On $10,000 invested in IVBIX, assuming 5% a year before costs, total costs come to $282 over 5 years, cutting the return by 0.47% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.44%) | $46 | $145 | $253 |
| Trading costs (broker commissions) | $1 | $2 | $3 |
| Lost growth on money paid in costs | $0 | $7 | $26 |
| Total costs | $47 | $154 | $282 |
| Value after costs | $10,453 | $11,422 | $12,481 |
| Impact on return, per year | 0.47% | 0.47% | 0.47% |
IVBIX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.0053%
- Total broker commissions: $21K
- Bought from dealers (principal trades, not a cost): $846.0M
- Portfolio turnover (prospectus): 128%
- Securities lending: none during the year
IVBIX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| ADVANTAGE SECURITIES LLC | $18K | 83.15% |
| TD SECURITIES (USA) LLC | $2K | 10.86% |
| CitiGroup Global Markets Inc. | $1K | 5.09% |
| BTIG, LLC | $104 | 0.49% |
| HSBC SECURITIES (USA) INC. | $86 | 0.41% |
IVBIX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BOFA SECURITIES, INC. | $126.2M | 20.22% |
| GOLDMAN SACHS & CO. LLC | $96.7M | 15.49% |
| JANNEY MONTGOMERY SCOTT LLC | $73.4M | 11.76% |
| BMO CAPITAL MARKETS CORP. | $64.5M | 10.34% |
| NOMURA SECURITIES INTERNATIONAL, INC. | $56.8M | 9.11% |
| STATE STREET GLOBAL MARKETS, LLC | $55.3M | 8.86% |
| CitiGroup Global Markets Inc. | $55.2M | 8.85% |
| WELLS FARGO SECURITIES, LLC | $35.2M | 5.64% |
| TD SECURITIES (USA) LLC | $32.4M | 5.19% |
| Santander Investment Securities Inc. | $28.4M | 4.55% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.